Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study

por Illini, Oliver, Fabikan, Hannah, Hochmair, Maximilian Johannes, Weinlinger, Christoph, Krenbek, Dagmar, Brcic, Luka, Setinek, Ulrike, Terbuch, Angelika, Absenger, Gudrun, Konjić, Selma, Valipour, Arschang
Publicado 2022

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung

por Brcic, Luka, Stanzer, Stefanie, Krenbek, Dagmar, Gruber-Moesenbacher, Ulrike, Absenger, Gudrun, Quehenberger, Franz, Valipour, Arschang, Lindenmann, Joerg, Stoeger, Herbert, Al Effah, Mohamed, Fediuk, Melanie, Balic, Marija, Popper, Helmut H.
Publicado 2018

Multimodal Treatment of Malignant Pleural Mesothelioma: Real-World Experience with 112 Patients

por Holzknecht, Arnulf, Illini, Oliver, Hochmair, Maximilian J., Krenbek, Dagmar, Setinek, Ulrike, Huemer, Florian, Bitterlich, Erwin, Kaindl, Christoph, Getman, Vladyslav, Akan, Ahmet, Weber, Michael, Leobacher, Gunther, Valipour, Arschang, Mueller, Michael R., Watzka, Stefan B.
Publicado 2022

Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis

por Hochmair, Maximilian J., Fabikan, Hannah, Illini, Oliver, Weinlinger, Christoph, Setinek, Ulrike, Krenbek, Dagmar, Prosch, Helmut, Rauter, Markus, Schumacher, Michael, Wöll, Ewald, Wass, Romana, Brehm, Elmar, Absenger, Gudrun, Bundalo, Tatjana, Errhalt, Peter, Urban, Matthias, Valipour, Arschang
Publicado 2020

In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer

por Dervovic, Dzana, Malik, Ahmad A., Chen, Edward L. Y., Narimatsu, Masahiro, Adler, Nina, Afiuni-Zadeh, Somaieh, Krenbek, Dagmar, Martinez, Sebastien, Tsai, Ricky, Boucher, Jonathan, Berman, Jacob M., Teng, Katie, Ayyaz, Arshad, Lü, YiQing, Mbamalu, Geraldine, Loganathan, Sampath K., Lee, Jongbok, Zhang, Li, Guidos, Cynthia, Wrana, Jeffrey, Valipour, Arschang, Roux, Philippe P., Reimand, Jüri, Jackson, Hartland W., Schramek, Daniel
Publicado 2023

Author Correction: In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer

por Dervovic, Dzana, Malik, Ahmad A., Chen, Edward L. Y., Narimatsu, Masahiro, Adler, Nina, Afiuni-Zadeh, Somaieh, Krenbek, Dagmar, Martinez, Sebastien, Tsai, Ricky, Boucher, Jonathan, Berman, Jacob M., Teng, Katie, Ayyaz, Arshad, Lü, YiQing, Mbamalu, Geraldine, Loganathan, Sampath K., Lee, Jongbok, Zhang, Li, Guidos, Cynthia, Wrana, Jeffrey, Valipour, Arschang, Roux, Philippe P., Reimand, Jüri, Jackson, Hartland W., Schramek, Daniel
Publicado 2023

Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program

por Illini, Oliver, Fabikan, Hannah, Swalduz, Aurélie, Vikström, Anders, Krenbek, Dagmar, Schumacher, Michael, Dudnik, Elizabeth, Studnicka, Michael, Öhman, Ronny, Wurm, Robert, Wannesson, Luciano, Peled, Nir, Kian, Waleed, Bar, Jair, Daher, Sameh, Addeo, Alfredo, Rotem, Ofer, Pall, Georg, Zer, Alona, Saad, Akram, Cufer, Tanja, Sorotsky, Hadas Gantz, Hashemi, Sayed M. S., Mohorcic, Katja, Stoff, Ronen, Rovitsky, Yulia, Keren-Rosenberg, Shoshana, Winder, Thomas, Weinlinger, Christoph, Valipour, Arschang, Hochmair, Maximilian J.
Publicado 2022